EET Analog Treatment Improves Insulin Signaling in a Genetic Mouse Model of Insulin Resistance

EET Analog Treatment Improves Insulin Signaling in a Genetic Mouse Model of Insulin Resistance james freeman diabetes freedom We previously showed that global deletion of the cytochrome P450 epoxygenase Cyp2c44, a major epoxyeicosatrienoic acid (EET) producing enzyme in mice, leads Read more

Empagliflozin Treatment is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes

Empagliflozin Treatment is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes james freeman diabetes freedom Sodium—glucose-cotransporter-2 (SGLT2) inhibitors reduce the risk of major adverse CV events and hospitalization Read more

Empagliflozin Treatment is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes

Empagliflozin Treatment is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes james freeman diabetes freedom Sodium—glucose-cotransporter-2 (SGLT2) inhibitors reduce the risk of major adverse CV events and hospitalization Read more

Diabetes, Drug Treatment and Mortality in COVID-19: A Multinational Retrospective Cohort Study

Diabetes, Drug Treatment and Mortality in COVID-19: A Multinational Retrospective Cohort Study james freeman diabetes freedom Patients with type 2 diabetes mellitus (T2DM) are at increased risk of severe COVID-19 outcomes possibly due to dysregulated inflammatory responses. Glucose-regulating medications such Read more

Diabetes, Drug Treatment and Mortality in COVID-19: A Multinational Retrospective Cohort Study

Diabetes, Drug Treatment and Mortality in COVID-19: A Multinational Retrospective Cohort Study james freeman diabetes freedom Patients with type 2 diabetes mellitus (T2DM) are at increased risk of severe COVID-19 outcomes possibly due to dysregulated inflammatory responses. Glucose-regulating medications such Read more

The Deterrence of Rapid Metabolic Decline within 3 Months after Teplizumab Treatment in Individuals at High Risk for Type 1 Diabetes

The Deterrence of Rapid Metabolic Decline within 3 Months after Teplizumab Treatment in Individuals at High Risk for Type 1 Diabetes james freeman diabetes freedom Endpoints that provide an early identification of treatment effects are needed to implement type 1 Read more

Is closed-loop glucose control an effective treatment for patients with type 2 diabetes with serious kidney disease?

Is closed-loop glucose control an effective treatment for patients with type 2 diabetes with serious kidney disease? dr freeman type 2 diabetes cure In a nutshell This study looked at the use of closed-loop glucose control treatment for patients with Read more

Alternative medicine or supplements for type 2 diabetes treatment

To learn more visit: http://www.AnimatedDiabetesPatient.com Following a healthy diet is always beneficial for patients with diabetes. Until such time as good evidence provides clear direction on dietary supplements, or organizations (such as the American Diabetes Association) provide clear authorization on Read more

Is liraglutide an effective add-on treatment for poorly controlled type 2 diabetes?

Is liraglutide an effective add-on treatment for poorly controlled type 2 diabetes? dr freeman type 2 diabetes cure In a nutshell This study evaluated whether liraglutide (Victoza) improves diabetic control in patients with difficult to control type 2 diabetes (T2D) and Read more

Practice Pearls: Overcoming Resistance to Treatment Intensification

Practice Pearls: Overcoming Resistance to Treatment Intensification dr james freeman diabetes freedom In this episode of Practice Pearls: Overcoming Therapeutic Inertia Dr. Andrew Bzowyckyj discusses overcoming resistance to treatment intensification. This is part of the American Diabetes Association’s Overcoming Therapeutic Read more

Effect of pioglitazone treatment in patients with prediabetes or type 2 diabetes mellitus and liver disease.

Effect of pioglitazone treatment in patients with prediabetes or type 2 diabetes mellitus and liver disease. dr freeman type 2 diabetes cure In a nutshell This study analyzed the effectiveness of pioglitazone (Actos) in patients with prediabetes or type 2 diabetes (T2D) Read more

Is dapagliflozin add-on a good treatment option for patients with type 2 diabetes on insulin?

Is dapagliflozin add-on a good treatment option for patients with type 2 diabetes on insulin? dr freeman type 2 diabetes cure In a nutshell In this study, the authors evaluated the effectiveness of adding dapagliflozin (Farxiga) to insulin therapy in patients with Read more